| Similar Articles |
|---|
 |
Bio-IT World
October 2005
Salvatore Salamone |
Supercomputing Contest Winner The winning entry involves high-throughput alignment and identification of micro-rearrangements in mammalian genomes for stem cell research.   |
Bio-IT World
June 2005
Salvatore Salamone |
Wanted: Tough Computational Problems Bio*IT World and Orion Multisystems have teamed to launch the Personal Supercomputing Contest intended to help a life science group tackle a difficult computational challenge by providing what amounts to four years of CPU time on an Orion personal supercomputer. |
Bio-IT World
February 10, 2003
Kevin Davies |
With a Click of the Mouse What do Eminem and Mus musculus have in common? About 30,000 genes, for a start. The author mulls over the second mammalian genome. |
The Motley Fool
September 29, 2010
Brian Orelli |
Careful What You Wish For, Stem Cell Investors Investors seem to have forgotten about fundamentals. |
InternetNews
April 27, 2005
Michael Singer |
Orion Workstation Strength Gets Personal NASA and a handful of universities pick up on the 'personal supercomputer' from Orion Multisystems, which has 96 nodes and can fit under a desk. |
Bio-IT World
April 15, 2003
Malorye Branca |
Beyond the Blueprint How will the wealth of data emanating from the human genome and allied technologies impact research on health and disease? |
Geotimes
May 2007
Kathryn Hansen |
Birds Evolve Small Genomes Pre-Flight The holes in fossil dinosaur bones are pointing out the holes in the theories of bird evolution. |
Pharmaceutical Executive
October 1, 2012
Ben Comer |
Stem Cells: A Promise Deferred? Ideology, politics, and a stilted political debate may be causing pharma to overlook the potential of emerging stem cell therapies in fostering a new generation of cures. |
Information Today
August 4, 2011 |
Elsevier Introduces Genome Viewer The Genome Viewer is a SciVerse application that displays detailed gene or genomic sequence information on the genes mentioned in an article. |
InternetNews
August 30, 2004
Michael Singer |
Orion Debuts Cluster Workstation The new company comes out of stealth mode with a family of business workstations that think like a cluster of servers. |
Bio-IT World
November 12, 2002
Kevin Davies |
DNA for Dummies? The journal Nature Genetics has just published a user's guide to the human genome -- and none too soon. |
BusinessWeek
June 13, 2005
Arlene Weintraub |
A Boost for Broken Hearts? The Institute of Regenerative Medicine in Barbados is convinced that stem cells from fetuses can repair cardiac damage. |
Chemistry World
October 26, 2006
Bea Perks |
Honeybee Genome Unveiled The humble honeybee is giving up its genetic secrets, now that scientists have unveiled the insect's entire genome sequence. Chemists have a lot to learn from the honeybee genome. |
Chemistry World
September 7, 2011 |
Bringing DNA to Life Clyde Hutchison's research focuses on the search for improved methods to learn about gene function from DNA sequence information. |
Bio-IT World
June 2005 |
New Products Orion Delivers Personal Supercomputer... Cray Taps Dual-Core CPUs for Server Lines... Microway Doubles Up on Navion Server Line... SAS Expands Offerings... Sun Powers Up Sun Fire Server Line... |
Bio-IT World
August 2005
Maureen McDonough |
U.K. Framework Offers Stem Cells a Future The United Kingdom has managed to cut through the noise surrounding stem cell research, creating a regulatory framework that fosters an environment of international collaboration and excellent R&D programs. And they try to do it all in an ethical way. |
Bio-IT World
December 10, 2002 |
Craig Venter Unvarnished (part II) The former Celera CEO covers privacy, ESTs, and his new research institutes. |
Bio-IT World
April 2006 |
Virtual Stem Cell Laboratory Goes Live Children's Hospital in Boston's Virtual Stem Cell Laboratory web site allows online visitors to manipulate and investigate a "living" culture of embryonic stem cells. |
The Motley Fool
November 9, 2004
Charly Travers |
Are Stem Cells a Rule Breaker? Does the science offer real hope or just hype? Biotech investors take on enough risk in the normal course of drug development that they do not need to worry about whether or not the underlying technology even works. |
